$MANE SEC Filings

VDPHL01, a novel orally-administered extended-release minoxidil formulation, met all primary and secondary endpoints with high statistical significance in both active treatment arms evaluating once-daily (QD) and twice-daily (BID) admini...

Received 9,650 shares as a grant or award · Granted 19,300 Stock Option (Right to Buy)

Sold 750,000 shares ($80.4M) · Received 300,000 shares by exercise

No securities owned

Received 3,452 shares by exercise or conversion ($42.1K) · Sold 43,500 shares ($4.69M)

Received 3,452 shares by exercise or conversion ($42.1K) · Sold 67,500 shares ($7.28M)

Sold 100,000 shares ($10.7M)